Where does Native Microbials, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Native Microbials, Inc. ranks #20,131 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Native Microbials, Inc. hold?

Native Microbials, Inc. holds 14 US utility patents granted between 2020 and 2024, spanning 11 technology areas.

What is Native Microbials, Inc.'s Innovation Score?

Native Microbials, Inc. has an Innovation Score of 43.4 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Native Microbials, Inc. focus on?

Native Microbials, Inc.'s top technology area is A23K (Fodder) with 13 patents, ranking #27 of 396 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Native Microbials, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Native Microbials, Inc..

What does claim depth mean for Native Microbials, Inc.'s patents?

Native Microbials, Inc.'s patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Native Microbials, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Native Microbials, Inc.

USPTO PatentsView assignee record - 14 granted patents across 11 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23K (Fodder).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Native ranks #20,131 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 11 technology areas.

#20,131
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.4/100): 22.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R20131 · US Corporation #20,131 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 14 grants
MID-PACK #20,131/49,997
PHOTO-FINISH Nalpropion Pharmaceu…
CPC-FOCUS A23K · 11 areas
INNOV-PAR 43.4/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Nalpropion Pharmaceuticals LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Native’s 43.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (22%) Velocity 8.9 pts (21%) Breadth 11.7 pts (27%) Claim depth 13.4 pts (31%)

Qualcomm Incorporated · highest

85
Native Microbials · this assignee

43
3D Lighting… · lowest

7

What this shows Native's Innovation Score is 43.4/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Native?

Each dot is one of Native’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Native’s own 22.4 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Native vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Native's grants concentrate

Native Microbials, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 92.9% of grants classified under A23K (Fodder). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2022. By volume, Native sits between Nalpropion Pharmaceuticals LLC and New Power Concepts LLC.

Native's three-year grant acceleration

Native Microbials, Inc. shows 8 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nalpropion Pharma…

14
Nanjing Horizon R…

14
Nanostar

14
National Diversif…

14
Neander Motors

14
Neuralight

14
Neurasignal

14
New Power Concepts

14
Native Microbials ◀

14

What this shows Native holds 14 patents at rank #20,157, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Native

By rank, the assignees closest to #20,157 in granted patent volume.

Leaders in A23K (Fodder)

Other assignees with the most granted patents in Native's primary technology class.

Native's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Native Microbials, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	21.4%
2021	3	21.4%
2022	1	7.1%
2023	1	7.1%
2024	6	42.9%

Which technologies does Native Microbials, Inc. patent most?

A23K - Fodder 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 5

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 4

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Native Microbials, Inc.'s patent record in context - here's where to go next.

Native Microbials, Inc.'s lead technology class is A23K (Fodder), 92.9% of its portfolio - see every assignee active in that class. Explore A23K
Ranked #20,131 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Native Microbials, Inc. against Nalpropion Pharmaceuticals LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.